Han Hui Zhang
Chief Executive Officer presso VANFUND URBAN INVESTMENT AND DEVELOPMENT CO., LTD.
Profilo
Han Hui Zhang has worked as a General Manager & Director at Vanfund Urban Investment & Development Co., Ltd.
since 2019.
Additionally, Mr. Zhang is currently a Director at Jilin Wanfang Baiao Biotechnology Co., Ltd.
Posizioni attive di Han Hui Zhang
| Società | Posizione | Inizio |
|---|---|---|
| VANFUND URBAN INVESTMENT AND DEVELOPMENT CO., LTD. | Chief Executive Officer | 20/05/2019 |
Jilin Wanfang Baiao Biotechnology Co., Ltd.
 Jilin Wanfang Baiao Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Vanfund Urban Investment & Development Co., Ltd., Jilin Wanfang Baiao Biotechnology Co., Ltd. manufactures and sells pharmaceutical products. The private company is based in Changchun, China. The Chinese company was founded in 2020. The CEO is Feng Chun Qi. Jilin Wanfang Baiao Biotechnology Co. was acquired by Vanfund Urban Investment & Development Co., Ltd. on January 26, 2022 for $3.29 million. | Director/Board Member | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VANFUND URBAN INVESTMENT AND DEVELOPMENT CO., LTD. | Technology Services |
| Aziende private | 1 |
|---|---|
Jilin Wanfang Baiao Biotechnology Co., Ltd.
Jilin Wanfang Baiao Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Vanfund Urban Investment & Development Co., Ltd., Jilin Wanfang Baiao Biotechnology Co., Ltd. manufactures and sells pharmaceutical products. The private company is based in Changchun, China. The Chinese company was founded in 2020. The CEO is Feng Chun Qi. Jilin Wanfang Baiao Biotechnology Co. was acquired by Vanfund Urban Investment & Development Co., Ltd. on January 26, 2022 for $3.29 million. | Health Technology |
- Borsa valori
- Insiders
- Han Hui Zhang
